OTC/Supplement Co-Packaging Policy In The Works At FDA
This article was originally published in The Tan Sheet
Executive Summary
Any future FDA guidance or regulation on co-packaging OTCs with dietary supplements would have to reflect the agency's resolution of concerns related to duration of use, dual-labeling and multiple claims for such products
You may also be interested in...
OTC/Supplement Combo Products Are In “Regulatory Limbo” – Attorney
FDA should include OTC drug/dietary supplement combinations in its combination products guidelines and place them under the jurisdiction of the Office of Combination Drugs, attorney Ralph Fucetola recommends
OTC/Supplement Combo Guidance, Sale Urged By Rep. Burton
House Government Reform Committee Chair Dan Burton (R-Ind.) is pressing FDA to explain its intentions regarding OTC drug/dietary supplement combination products
OTC/Dietary Supplement Combos Cited In FDA Warning Letters
The presence of acetaminophen in OTC/dietary supplement combination products renders them drugs, FDA says in recent warning letters to two companies.